Lantern Pharma Inc. (LTRN)
Lantern Pharma Inc. is a clinical-stage biotechnology firm dedicated to revolutionizing drug development through the strategic application of artificial intelligence, machine learning, and comprehensive genomic data analysis. Their primary drug candidate, LP-100, is currently undergoing Phase II clinical trials, targeting metastatic, castration-resistant prostate cancer. The company is also advancing LP-300 as a potential combination therapy for non-small cell lung cancer adenocarcinoma, specifically in individuals who are non-smokers or have never smoked. Furthermore, their preclinical pipeline includes LP-184, an alkylating agent engineered to inflict DNA damage upon cancer cells that either overexpress specific biomarkers or exhibit mutations within their DNA repair pathways. Beyond these, Lantern Pharma maintains an antibody-drug conjugate (ADC) program for diverse cancer treatments. Central to their operations is the RADR artificial intelligence platform, which synergizes molecular data through advanced big data analytics and machine learning capabilities. Established in 2013, the company operates from its headquarters in Dallas, Texas.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Lantern Pharma Inc.
NASDAQ:LTRNHealthcare · Biotechnology
-9.60%$0.6608
AH$0.6608+0.00%vs close
Mkt Cap$9.87M
Float13.8M
O/S14.94M
Vol
$ Vol
RVOL
Inst Own19.3%
SI2.8%
Earnings
Dilution
Financials Summary
Revenue$0
Net Income-$17.12M
Total Assets$11.04M
Free Cash Flow-$15.68M
Debt & Equity
Debt 92%
Equity 8%
Total Debt$78.54M
Total Equity$6.53M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in LTRN's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$11.04M
Liabilities$4.5M
Accounts Receivable$30K
Accounts Payable$4.42M
Inventory$0
PP&E (Net)$107.47M
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | - | - | - | - | - | - | - | - |
| Cost of Revenue | $0 | $0 | $175K | $0 | $0 | $0 | $2K | -$3K |
| Gross Profit | $0 | $0 | -$175K | $0 | $0 | $0 | -$2K | $3K |
| Gross Margin | - | - | - | - | - | - | - | - |
| Research and Development | $11.51M | $16.13M | $11.89M | $8.6B | $7.57M | $2.24M | $953K | $572K |
| Selling, General, and Administrative | $6.46M | $6.09M | $5.98M | $5.83B | $5.02M | $3.66M | $1.48M | $1.15M |
| Other | $0 | $0 | -$175K | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $17.98M | $22.22M | $17.7M | $14.43B | $12.59M | $5.91M | $2.43M | $1.73M |
| Operating Income (EBIT) | -$17.98M | -$22.22M | -$17.88M | -$14.43B | -$12.59M | -$5.91M | -$2.43M | -$1.73M |
| Operating Margin | - | - | - | - | - | - | - | - |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Interest Income | $438K | $742K | $765K | $204.35M | $68K | $0 | $0 | $0 |
| Other Income (Expense) | $859K | $1.44M | $1.92M | $172.81M | $228K | $0 | $0 | $0 |
| Income Before Tax (EBT) | -$17.12M | -$20.78M | -$15.96M | -$14.26B | -$12.36M | -$5.91M | -$2.43M | -$1.73M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $3K |
| Net Income | -$17.12M | -$20.78M | -$15.96M | -$14.26B | -$12.36M | -$5.91M | -$2.43M | -$1.73M |
| Net Income Margin | - | - | - | - | - | - | - | - |
| Supplementary Data | ||||||||
| EPS | -1.57 | -1930.92 | -1.47 | -1.31 | -1.13 | -0.95 | -0.39 | -0.28 |
| Diluted EPS | -1.57 | -1930.92 | -1.47 | -1.31 | -1.13 | -0.95 | -0.39 | -0.28 |
| Weighted Average OS | 10.90M | 10.76M | 10.84M | 10.85M | 10.90M | 6.22M | 6.27M | 6.22M |
| EBITDA | -$17.1M | -$20.76M | -$15.95M | -$14.26B | -$12.36M | -$5.9M | -$2.43M | -$1.73M |
| EBITDA Margin | - | - | - | - | - | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Assets | ||||||||
| Current Assets | ||||||||
| Cash and Cash Equivalents | $4.42M | $7.51M | $21.94M | $37.2M | $51.52M | $19.23M | $1.23M | $445K |
| Short-Term Investments | $5.7M | $16.5M | $19.36M | $17.99M | $19.2M | $0 | $0 | $0 |
| Cash and Short-Term Investments | $10.12M | $24.01M | $41.3M | $55.2M | $70.73M | $19.23M | $1.23M | $445K |
| Accounts Receivable | $30K | $0 | $860K | $0 | $181K | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $0 | $1.23M | $746K | $541K | $379K | $0 | $0 | $0 |
| Total Current Assets | $10.8M | $25.25M | $43.34M | $58.72M | $72.72M | $20.24M | $1.23M | $445K |
| Long-Term Assets | ||||||||
| Property, Plant & Equipment Net | $107.47M | $287K | $280K | $96K | $216K | $22K | $9K | $5K |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $1M | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | -$107.24M | $37K | $26K | $18K | $18K | $101K | $191K | $0 |
| Total Long-Term Assets | $233K | $324K | $306K | $114K | $1.23M | $123K | $200K | $5K |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $11.04M | $25.57M | $43.65M | $58.84M | $73.95M | $20.36M | $1.43M | $450K |
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts Payable | $4.42M | $0 | $942K | $0 | $2.17M | $432K | $478K | $98K |
| Short-Term Debt | $78.54M | $0 | $0 | $0 | $152K | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | -$78.46M | $4.14M | $1.56M | $2.75M | $0 | $120K | $2K | $535K |
| Total Current Liabilities | $4.5M | $4.33M | $2.68M | $2.8M | $2.33M | $552K | $489K | $652K |
| Long-Term Liabilities | ||||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $109K | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $4K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Long-Term Liabilities | $4K | $53K | $61K | -$0 | $53K | $109K | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $4.5M | $4.38M | $2.74M | $2.8M | $2.38M | $661K | $489K | $652K |
| Stockholders' Equity | ||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $14K | $7K |
| Common Stock | $1K | $1K | $1K | $1K | $1K | $622 | $11K | $11K |
| Retained Earnings | -$93.15M | -$76.03M | -$55.24M | -$39.28M | -$25.02M | -$12.66M | -$6.75M | -$4.32M |
| Comprehensive Income & Other | $25K | $154K | -$107K | -$371K | -$93K | $0 | $0 | $0 |
| Other Stockholders' Equity | $99.68M | $97.21M | $96.15M | $95.32M | $96.59M | $32.36M | $7.68M | $4.11M |
| Total Equity | $6.53M | $21.19M | $40.91M | $56.04M | $71.57M | $19.7M | $943K | -$202K |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $11.04M | $25.57M | $43.65M | $58.84M | $73.95M | $20.36M | $1.43M | $450K |
| Supplementary Data | ||||||||
| Total Debt | $78.54M | $244K | $234K | $53K | $205K | $109K | $0 | $0 |
| Net Debt | $74.12M | -$7.27M | -$21.7M | -$37.15M | -$51.32M | -$19.12M | -$1.23M | -$445K |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Operating Activities | ||||||||
| Net Income | -$17.12M | -$20.78M | -$15.96M | -$14.26M | -$12.36M | -$5.91M | -$2.43M | -$1.73M |
| Depreciation & Amortization | $17K | $17K | $15K | $10K | $7K | $3K | $2K | -$3K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $651K | $733K | $1.07M | $1.19M | $962K | $1.19M | $118K | $186K |
| Changes in Working Capital: | ||||||||
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $187K |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | $0 | $0 | $0 | $0 | $0 | $0 | $373K | $70K |
| Other Working Capital | $635K | $2.23M | $538K | -$612K | $600K | -$939K | -$192K | $272K |
| Total Working Capital Change | $635K | $2.23M | $538K | -$612K | $600K | -$939K | $181K | $272K |
| Other Non-Cash Items | $139K | -$10K | -$5K | $906K | $203K | $0 | $0 | -$76K |
| Net Cash from Operating | -$15.68M | -$17.81M | -$14.35M | -$12.77M | -$10.59M | -$5.65M | -$2.13M | -$1.27M |
| Investing Activities | ||||||||
| Capital Expenditures | -$2K | -$13K | -$19K | -$28K | -$15K | -$16K | -$6K | $0 |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $5K |
| Purchases of Investments | -$14.72M | -$17.28M | -$8.2M | -$3.91M | -$19.58M | $0 | $0 | $0 |
| Sales of Investments | $25.78M | $20.66M | $7.28M | $4.12M | $64K | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $5K |
| Net Cash from Investing | $11.06M | $3.37M | -$930K | $179K | -$19.53M | -$16K | -$6K | $5K |
| Financing Activities | ||||||||
| Debt Repaid | - | - | - | - | - | -$109K | - | - |
| Common Stock Issuance | $1.64M | $67K | $0 | $0 | $69M | $26.25M | $2.92M | $0 |
| Common Stock Repurchases | $0 | $0 | -$500K | -$2.48M | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | -$140K | $0 | $0 | $2.78M | -$4.64M | -$28.94M | $0 | $535K |
| Net Cash from Financing | $1.5M | $67K | -$500K | -$2.18M | $63.42M | $23.66M | $2.92M | $535K |
| Forex Effect | $33K | -$50K | -$28K | -$11K | $1K | $0 | $0 | $0 |
| Net Change in Cash | -$3.09M | -$14.43M | -$15.81M | -$14.78M | $33.3M | $18M | $787K | -$731K |
| Supplementary Data | ||||||||
| Operating Cash Flow | -$15.68M | -$17.81M | -$14.35M | -$12.77M | -$10.59M | -$5.65M | -$2.13M | -$1.27M |
| Capital Expenditure | -$2K | -$13K | -$19K | -$28K | -$15K | -$16K | -$6K | $0 |
| Free Cash Flow | -$15.68M | -$17.83M | -$14.37M | -$12.8M | -$10.61M | -$5.67M | -$2.13M | -$1.27M |
| Cash at Beginning | $7.51M | $21.94M | $37.74M | $52.52M | $19.23M | $1.23M | $445K | $1.18M |
| Cash at End | $4.42M | $7.51M | $21.94M | $37.74M | $52.52M | $19.23M | $1.23M | $445K |